TYP Price sensitive 21 Jul 2025, 8:26 AM

Patient recruitment for world first TRP-8803 trial underway

Tryptamine Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in